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Abstract 1 
Objective The aim of this study was to determine whether lumbosacral epidural 2 
administration of magnesium sulphate added to ropivacaine prolongs and improves 3 
perioperative analgesia, without adverse effects on motor block duration or hind limb 4 
neurological function, in dogs undergoing hip arthroplasty.  5 
Study design Investigator-blind, controlled, randomized, prospective clinical trial. 6 
Animals Twenty client-owned dogs undergoing hip arthroplasty were allocated 7 
randomly to either group C (control, 1 mg kg-1 epidural ropivacaine) or group M 8 
(magnesium, epidural injection of 1 mg kg-1 ropivacaine and 2 mg kg-1 magnesium 9 
sulphate).  10 
Methods All dogs were premedicated with intramuscular acepromazine. General 11 
anaesthesia was induced with propofol, and maintained with isoflurane in oxygen. 12 
Intraoperatively, nociception was assessed based on changes in heart rate, respiratory 13 
rate, and mean arterial pressure above baseline values. Postoperatively, pain was 14 
evaluated with a Sammarco pain score, a Glasgow pain scale and a visual analogue 15 
scale. The Tarlov’s scale was used to quantify motor block. All dogs were evaluated at 16 
recovery and then 1, 2, 3, 4, 5 and 24 hours after that. Rescue analgesia was provided 17 
during surgery with fentanyl and, postoperatively, with buprenorphine. Groups were 18 
compared using one way repeated measures analysis of variance followed by Holm-19 
Sidak method for multiple comparison, or non-parametric tests when appropriate. 20 
Results The two treatment groups did not differ (p > 0.05) with respect to intraoperative 21 
physiological variables, rescue analgesia, postoperative pain scores (Sammarco q = 22 
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1.00; Glasgow q = 3.10; VAS q = 0.50) and duration of the motor block (Tarlov’s q = 23 
2.40).     24 
Conclusions and clinical relevance The addition of epidural magnesium to ropivacaine 25 
did not improve or prolong the analgesia provided by ropivacaine alone. Further studies 26 
are needed to determine whether an epidural magnesium dose higher than 2 mg kg-1 27 
would exert better analgesia, without causing adverse effects, in dogs undergoing 28 
orthopaedic surgery.  29 
Keywords dog, magnesium sulphate; neuroaxial anaesthesia, perioperative analgesia, 30 
ropivacaine 31 
  32 
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Introduction 33 
Total hip replacement is an innovative and invasive surgery used in dogs to treat hip 34 
dysplasia and other pathological conditions affecting the coxofemoral joint. 35 
Providing adequate perioperative analgesia during invasive orthopaedic procedures not 36 
only is an ethical obligation for the veterinarian, but also plays a crucial role in the 37 
outcome of the surgery itself (Conzemius et al. 2005). Indeed, effective prevention and 38 
treatment of pain has been shown to significantly improve dogs’ attitude, as well as 39 
limb’s use and function in dogs undergoing major orthopaedic surgery (Conzemius et 40 
al. 2005).  41 
 42 
As an alternative to systemic analgesia, loco-regional anaesthetic techniques offer the 43 
advantage of a selective and targeted block of the anatomical area of interest. Among 44 
neuroaxial techniques, epidural administration of analgesics is traditionally regarded as 45 
safer and easier to perform than the spinal route. Owing to its popularity, practicality 46 
and ease of performance, single epidural injection is usually preferred to constant rate 47 
infusion of analgesics via this route, which can only be accomplished after insertion of 48 
an epidural catheter. Placing an epidural catheter is a time-consuming procedure, which 49 
requires a certain degree of expertise and carries the risk of complications (Ladha et al. 50 
2013; Pumberger et al. 2013). Nevertheless, single epidural injections may provide 51 
analgesia of insufficient duration when invasive and potentially long surgeries are 52 
performed.  53 
 54 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
4 
 
Within the last twenty years, there has been an increasing interest in the multimodal 55 
approach to pain management in veterinary patients, especially with respect to the use 56 
of agents which, despite not being listed among classical analgesics, exert 57 
antinociceptive effects (Kukanich 2013; Madden et al. 2014; Crociolli et al. 2015; 58 
Norkus et al. 2015). Among these, magnesium plays a central role in the prevention of 59 
central sensitization by blocking the dorsal horn N-methyl-D-aspartate (NMDA) 60 
receptors in a non-competitive, voltage dependent fashion. Magnesium sulphate is 61 
inexpensive, and available in Europe as a formulation that is stable at room temperature 62 
and approved for parenteral administration in dogs. The potential for neurotoxicity 63 
when magnesium is administered intrathecally was investigated in dogs, and 64 
neurological impairment and histopathological lesions of the spinal cord were not found 65 
after a dose of 3 mg kg-1 (Simpson et al. 1994). The studies investigating the clinical 66 
role of magnesium as adjuvant in pain therapy show conflicting results. Intravenous 67 
magnesium failed to improve perioperative pain in both humans and dogs (Rioja et al. 68 
2012; Murphy et al. 2013). Conversely, several clinical trials showed that magnesium 69 
effectively improves analgesia in human patients receiving combinations of local 70 
anaesthetics and opioids, by either epidural or spinal route (Buvanendran et al. 2002; 71 
Oezalevli et al. 2005; Arcioni et al. 2007). The antinociceptive effects of epidural 72 
magnesium were demonstrated experimentally in dogs (Bahrenberg et al. 2015), 73 
however there is a paucity of data regarding the clinical use of magnesium in this 74 
species. A clinical trial suggests that adding spinal magnesium to ropivacaine increases 75 
the duration and the intensity of analgesia, but also of the motor block, provided by 76 
ropivacaine alone in dogs undergoing orthopaedic surgery (Adami et al. 2016).  77 
 78 
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The aim of this study was to determine whether the addition of magnesium sulphate to 79 
epidural ropivacaine would result in better perioperative analgesia, defined as longer 80 
duration and decreased rescue analgesia requirement, than ropivacaine alone, in client-81 
owned dogs anaesthetised for elective hip arthroplasty.  82 
Our hypothesis was that the addition of magnesium to ropivacaine would improve 83 
perioperative analgesia, without prolonging the motor block or causing neurological 84 
dysfunction of the hind limbs. 85 
 86 
Materials and methods 87 
This clinical study was designed as an investigator-blind, controlled, randomized, 88 
prospective trial.  89 
Twenty client-owned dogs scheduled for hip arthroplasty between March 2014 and 90 
February 2016 were recruited for this study. The number of dogs was determined based 91 
on a sample size calculation. Each group was to be composed of a minimum of 10 dogs 92 
to detect, with one-way analysis of variance (with power equal to 0.95 level of 93 
confidence and α value and standard deviation set at 0.05 and 40 minutes, respectively), 94 
a difference between groups in the mean duration of analgesia (defined as the time from 95 
the epidural injection to the administration of the first dose of rescue analgesic agent) 96 
equal to at least 60 minutes. 97 
Inclusion criteria were American Society of Anaesthesiologists (ASA) risk category 98 
lower than III and absence of skin infections at the level of the lumbosacral area. All 99 
dogs underwent a preanaesthetic physical examination and a complete blood test, 100 
including haematology and biochemistry, to rule out abnormalities. The permission of 101 
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the Ethical Committee of the Veterinary Teaching Hospital of the University of Turin 102 
(Italy), as well as a written consent signed by the dogs’ owners, was obtained prior to 103 
enrolment.  104 
All dogs were premedicated with intramuscular (IM) acepromazine (0.03 mg kg-1, 105 
Prequillan; Fatro, Italy). Thereafter, intravenous (IV) propofol (Vetofol; Esteve, Spain) 106 
was titrated to effect to induce general anaesthesia. After orotracheal intubation, 107 
isoflurane (Isoflo; Esteve, Spain) was delivered in oxygen via a circle system and 108 
lactated Ringer’s solution was perfused IV (10 mL kg-1 hr-1, Ringer Lattato; Fresenius 109 
Kabi, Italy). Arterial blood pressure [systolic (SAP), mean (MAP) and diastolic (DAP)] 110 
was measured continuously through an indwelling catheter placed in the dorsal pedal 111 
artery. Monitoring during anaesthesia included both cardiovascular [SAP, MAP, DAP, 112 
heart rate (HR) and rhythm) and respiratory [end tidal carbon dioxide (PE´CO2), peak 113 
inspiratory pressure (PIP), respiratory rate (fR), tidal volume (VT), minute volume (VE), 114 
inspired fraction of oxygen (FIO2), end tidal isoflurane tension (PE´ISO]) parameters, as 115 
well as oesophageal temperature (T°, C). Manual data recording was performed every 5 116 
minutes for the entire duration of anaesthesia. Spontaneous breathing was preferred 117 
unless PE´CO2 reached more than 45 mmHg (5.9 kPa) when mechanical ventilation was 118 
used to maintain normocapnia. The target PE´ISO was 1.3%, which is equal to the 119 
Minimum Alveolar Concentration (MAC) as determined in dogs (Valverde et al. 2003).  120 
As soon as the anaesthesia plane was deemed surgical based on classical clinical 121 
parameters (relaxation of the jaw, absence of blinking and movements, light palpebral 122 
reflex and normal canine physiological parameters) the anaesthetist (EL), who was 123 
unaware of the epidural treatment, performed all the epidural injections. 124 
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The dogs were positioned in sternal recumbency with the hind limbs cranial to 125 
maximize the dorsal lumbosacral space. The ilium wings, together with the sacrum and 126 
the dorsal spinous processes of L6 and L7, were used as anatomical landmarks. After 127 
surgical preparation of the area, a 75 mm, 19 gauge spinal needle (BD Needles; Becton 128 
Dickinson, Spain) was inserted percutaneously between L7 and S1, with the bevel 129 
facing cranial, and then advanced through the intervertebral ligament into the epidural 130 
space. Both the “popping” sensation, perceived while penetrating the interarcuate 131 
ligament, and the hanging drop technique with saline were used as a first assessment of 132 
proper needle placement. Radiographic exam followed to confirm correct positioning of 133 
the needle between L7 and S1. A horizontal beam was used to maintain positioning in 134 
sternal recumbency during injection. 135 
A block randomization method was used to allocate the dogs into one of two epidural 136 
treatment groups. Briefly, an operator not participating to the assessments was in charge 137 
of keeping an opaque, sealed envelope from which treatment assignments were shuffled 138 
and drawn. This same operator was also responsible for the list of allocations until the 139 
end of data collection.  140 
Epidural ropivacaine (Naropina 0.5%; AstraZeneca, Italy), 1 mg kg-1 (volume: 0.2 mL 141 
kg-1), was administered epidurally to group C (Control), while group M (Magnesium) 142 
was treated with ropivacaine (1 mg kg-1; volume: 0.2 mL kg-1) and magnesium sulfate 143 
(Magnesio Solfato 2g 10 mL-1; Galenica Senese, Italy) at the dose of 2 mg kg-1 144 
(volume: 0.01 mL kg-1). The drugs were mixed in the same syringe and administred as a 145 
single bolus over 1 minute. Doses were chosen based on the authors’ past clinical 146 
experience, and human and veterinary medical literature (Arcioni et al. 2007; Bilir et al. 147 
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2007; Oezalevli et al. 2005). After the epidural injection was performed, the dogs 148 
remained in sternal recumbency for 5 minutes. 149 
A bolus of IV atropine (0.01 mg kg-1, Atropina Solfato; ATI, Italy) was injected in the 150 
event of bradycardia (<45 beats minute-1). Treatment of hypotension (MAP <60 151 
mmHg) consisted of an IV bolus of lactated Ringer’s solution (10 mL kg-1 over 10 152 
minutes), followed by an IV colloid bolus (Voluven; Fresenius Kabi, Italy; 2 mL kg-1 153 
over 10 minutes), and then by an IV infusion of dopamine (Revivan; AstraZeneca, Italy; 154 
starting at 10 µg kg-1 minute-1, increased in increments of 2.5 µg kg-1 minute-1 every 10 155 
minutes until MAP increased above 60 mmHg) in the event of unresponsive 156 
hypotension. Bradyarrhythmias and hypotension occurring shortly after the epidural 157 
injection were regarded as clinical symptoms compatible with either sympathetic nerve 158 
blockade or hypermagnesaemia, and their occurrence was recorded.  159 
Intraoperative nociception was defined as an increase in HR, MAP and/or fR of at least 160 
20% compared to the baseline (recorded before skin incision, after PE´ISO
 
had been 161 
maintained constant at 1.3% for at least three consecutive measurements, over 15 162 
minutes). When two of these three parameters increased above the defined values, 163 
rescue fentanyl (Fentanest; Pfizer, Italy) was administered IV (0.003 mg kg-1). 164 
The duration of surgery and of anaesthesia (minutes) were recorded. The time elapsed 165 
from termination of inhalational anaesthesia to recovery in intensive care unit (minutes) 166 
was defined as “time to recovery”, and recorded. The trachea was extubated after return 167 
of swallowing and palpebral reflexes, accompanied by increased jaw tone. At this point, 168 
all dogs were administered with IV carprofen (4 mg kg-1, Rimadyl; Pfizer, Italy).  169 
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Postoperatively, a multifactorial pain score modified from Sammarco ranging from 0) 170 
no pain to 13) extreme pain (Appendix 1; Sammarco et al. 1996; Adami et al. 2012) and 171 
the short form of the Glasgow pain scale ranging from 0) no pain to 20) extreme pain 172 
(Holton et al. 2001) were used to evaluate pain. Additionally, a 10 cm visual analogue 173 
scale (VAS) with end points labelled 0) worst possible pain to 10) absence of pain was 174 
utilized. Rescue analgesia consisted of 0.01 mg kg-1 buprenorphine IV (Temgesic; 175 
Schering Plough, UK), administered when at least one pain score was 40% or more of 176 
the maximum value of the scale (<6 for the VAS, >5 for the multifactorial pain score 177 
scale, >8 for the Glasgow pain scale). A modified Tarlov’s scale (Appendix 2) ranging 178 
from 0) neurological impairment to 4) no signs of motor block (Buvanendran et al. 179 
2002; Adami et al. 2016) was used for neurological assessment of the hind limbs and 180 
quantification of motor blockade. The same observer (EL), who was unaware of the 181 
treatment, performed all the evaluations. All dogs were evaluated when deemed awake 182 
enough to respond to vocal call and incitement to sit or stand up, and then 60, 120, 180, 183 
240, 300 minutes and 24 hours after the end of surgery and before being discharged 184 
from the hospital.  185 
Statistical analysis was accomplished with commercially available software (SigmaStat 186 
and SigmaPlot 12, Systat Software Inc.). Normality of data distribution was assessed 187 
with the Kolmogorov-Smirnov test and with the Shapiro-Wilk test. Continuous 188 
variables were analysed with either one way repeated measures analysis of variance 189 
followed by Holm-Sidak method for multiple comparison, or Friedman repeated 190 
measures analysis of variance on ranks followed by Tukey test, where it applied. For the 191 
analysis of intraoperative cardiovascular and respiratory variables, only the values 192 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
10 
 
recorded during three significant events were used: 0) before surgery (baseline as above 193 
described), 1) 30 seconds after skin incision and 2) during femoral head osteotomy.  194 
For non-continuous variables, either a T-test or Mann Whitney Rank Sum test were 195 
used. Within each treatment group, the proportions of dogs which experienced 196 
hypotension and bradyarrhythmias following epidural injection of magnesium were 197 
analysed with the Fisher exact test. P values < 0.05 and q values < 2 were considered 198 
statistically significant.   199 
 200 
 201 
Results 202 
Data are presented as either mean ± standard deviation or median (range). Twenty dogs 203 
(12 female and 8 male) of various breeds, aged 12 (9-144) months completed this study.  204 
Heart rate, MAP, time to recovery and duration of anaesthesia were normally 205 
distributed. Anaesthesia was uneventful in all dogs enrolled in the study and lasted 222 206 
± 62 minutes in group M and 220 ± 32 minutes in group C, respectively; this difference 207 
was not statistically significant. The treatment groups were not statistically different to 208 
each other with respect to intraoperative physiological variables. However, HR 209 
decreased over time in the control group while MAP increased in both groups (Fig. 1). 210 
Respiratory rate increased over time in group M while it decreased in group C (Fig. 1). 211 
Cardiovascular events compatible with hypermagnesaemia, namely bradyarrhythmias 212 
and hypotension, were not observed during the anaesthetics. Three dogs of group M [0 213 
(0-1)] and 4 of group C [0 (0-2)] required boluses of rescue fentanyl during surgery. 214 
This difference was not statistically significant. There was no difference in the duration 215 
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of surgery, which lasted 120 (90-150) and 125 (100-150) minutes in groups M and C, 216 
respectively, was detected between groups. Only one dog, assigned to group C, required 217 
rescue buprenorphine before completion of pain assessments according to both the 218 
Sammarco and VAS scores (7 and 6.8, respectively). 219 
There was no significant difference between groups C and M in the VAS, Sammarco, 220 
Glasgow and Tarlov’s scores. In both groups, the Sammarco, the Glasgow and the 221 
Tarlov’s scores significantly increased over time, while VAS decreased (Fig. 2).  222 
Recovery was smooth and normal motor function of the hind limbs was observed within 223 
6 hours of the epidural injection in all dogs. Perianaesthetic complications were not 224 
observed. 225 
 226 
Discussion 227 
This study failed to demonstrate that the addition of magnesium to epidural ropivacaine 228 
provides superior perioperative analgesia, in terms of both duration and quality, than 229 
ropivacaine alone in dogs undergoing total hip replacement. The duration of the motor 230 
block was also comparable between the two groups, and the administration of 231 
magnesium was not associated with neurological dysfunction of the hind limbs.  232 
 233 
These findings were unexpected and not consistent with those of a previous study, 234 
which found that the addition of spinal magnesium to ropivacaine potentiated the 235 
intensity and the duration of analgesia in dogs after tibial plateau levelling osteotomy 236 
(Adami et al. 2016), but also prolonged the duration of the motor block.  237 
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Possible explanations for this discrepancy are less effective analgesia when magnesium 238 
is administered epidurally compared to the spinal route or, alternatively, a failure in the 239 
methods used in the current study to detect a difference between treatments.  240 
Besides the possibility of a direct analgesic effect of magnesium on the dorsal horn 241 
NMDA receptors, Adami and colleagues (2016) hypothesized that the ionized 242 
magnesium released by its salt may exert antinociception also by blocking the calcium 243 
channels, which in turn could alter the resting potential of the neuronal membranes. 244 
Alternatively, as a hyperosmolar salt, magnesium sulfate might cause osmotic 245 
interference with the cerebrospinal fluid and spinal cord, leading to neuronal shrinking 246 
and transient neurologic dysfunction (Busselberg et al. 1994). However, this hypothesis 247 
could not be tested because the actual osmolality of the solution to be injected could not 248 
be measured. Moreover, both mechanisms are more likely to occur when magnesium is 249 
injected spinally rather than epidurally because we suspect that a higher concentration is 250 
achieved in the cerebrospinal fluid when the dose is injected spinally.  251 
Another reasonable explanation is that the epidural route of administration requires a 252 
higher magnesium dose than the spinal one in order to detect appreciable analgesia. 253 
Owing to ethical obligations, and not to cause any harm to client-owned dogs, it was 254 
decided to use 2 mg kg-1 magnesium. This dose was proven to be safe in terms of risks 255 
of direct neurotoxicity (Simpson et al. 1994) and hypermagnesaemia (Adami et al. 256 
2016). Nonetheless, it cannot be excluded that a higher magnesium sulfate dose might 257 
have resulted in more pronounced clinical effects.  258 
 259 
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Pain assessment in non-verbal patients can be extraordinarily challenging even for 260 
experienced observers, especially when subjective indicators, namely behavioural signs 261 
of pain, are evaluated (Conzemius et al. 1997; Reid et al. 2007). The choice of having 262 
one single investigator in charge of all the assessments, as well as of using several pain 263 
scales instead of one, should have helped overcome some potential intrinsic limitations, 264 
namely the interobserver variability and the poor sensitivity and specificity of the scales 265 
used to evaluate pain.    266 
Lower pain score intervention levels might have resulted in detectable differences in 267 
postoperative analgesia between treatments. For consistency, it was decided to use the 268 
same cut-off value for all pain scales, which was set at 40% of the maximum possible 269 
score. Similar cut-off values of the VAS have been previously used in dogs, as well as 270 
in other animal species, to guide the administration of rescue analgesics during the 271 
postoperative period (Adami et al. 2011; Adami et al. 2012). Moreover, it has been 272 
suggested that, in human patients, 40% of the VAS scale may represent the limit 273 
between mild and moderate pain (Serlin et al. 1995; Bodian et al. 2001;).  274 
Another potential limitation of this study is the absence of irrefutable proof that the 275 
needle had been correctly placed within the epidural space in all dogs. Although the 276 
hanging drop technique was used to guide the needle’s insertion, and radiography to 277 
verify the needle’s position within the targeted intervertebral space, only epidurography, 278 
accomplished with the injection of a contrast medium, would have inarguably 279 
confirmed that the tip of the needle had reached the adequate depth. Due to ethical 280 
considerations for the client-owned dogs, the use of invasive or potentially harmful 281 
techniques for this purpose was not considered. Failure to identify the exact injection 282 
site could have distorted the results; however, the little or no postoperative rescue 283 
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analgesia requirement, together with the detection of motor blockade in all dogs at 284 
recovery, suggests that the epidural injections were correctly performed. 285 
Assuming that all the injections had been performed within the epidural space, an 286 
alternative possible explanation for the lack of differences between the two treatments is 287 
that ropivacaine alone, at the dose and concentration used in the current study, might 288 
already be adequate as analgesic treatment for hip replacement. Moreover, carprofen 289 
was administered to all dogs in recovery, which could have contributed to postoperative 290 
analgesia and made the detection of differences between groups even more challenging. 291 
In this scenario, detecting an appreciable difference would be more challenging and 292 
possibly require a larger sample size. Unfortunately, the use of a suboptimal analgesic 293 
treatment, namely a subclinical ropivacaine dose or even epidural saline, would have 294 
raised some ethical concerns. 295 
 296 
Serum magnesium concentrations were not measured. Although mild increases in 297 
ionised magnesium concentration might have gone undetected, it is reasonable to 298 
assume that a clinically relevant hypermagnesaemia would have been accompanied by 299 
cardiac arrhythmias and, possibly, persistent hypotension, none of which were observed 300 
in this study population. Moreover, one study found that 2.5 mg kg-1 of epidural 301 
magnesium did not result in clinical signs of hypermagnesaemia in dogs (Bahrenberg et 302 
al. 2015). 303 
 304 
Conclusions 305 
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In conclusion, the addition of 2 mg kg-1 magnesium sulphate to epidural ropivacaine did 306 
not result in considerable improvement of quality and duration of perioperative 307 
analgesia, nor did it prolong the motor block. Further trials are needed to determine 308 
whether a higher dose of magnesium administered via the epidural route would increase 309 
the analgesic effect in dogs undergoing orthopaedic surgery. 310 
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Appendix 1 
Modified multifactorial pain score (Sammarco et.al., 1996; Adami et al., 2012) to assess 
post-operative pain in 20 dogs undergoing total hip replacement. 
 The same observer who was blind to the treatment evaluated the dogs as soon as they were awake 
enough to respond to stimulation (vocal call and incitement to sit or stand up) and then 60, 120, 
180, 240, 300 minutes and 24 hours after surgery.  
 
Vocalization  
-None  
-Intermittent vocalization  
-Continuous vocalization  
  
0  
1  
2  
  
0  
1  
2  
  
0  
1  
2  
  
0  
1  
2  
  
0  
1  
2  
  
0  
1  
2  
  
0  
1  
2  
  
0  
1  
2  
Movement  
-None  
-Frequent position changes  
- Rolling, thrashing  
  
0  
1  
2  
  
0  
1  
2  
  
0  
1  
2  
  
0  
1  
2  
  
0  
1  
2  
  
0  
1  
2  
  
0  
1  
2  
  
0  
1  
2  
Agitation  
-Calm  
-Mild agitation  
-Moderate agitation  
-Severe agitation  
  
0  
1  
2  
3  
  
0  
1  
2  
3  
  
0  
1  
2  
3  
  
0  
1  
2  
3  
  
0  
1  
2  
3  
  
0  
1  
2  
3  
  
0  
1  
2  
3  
  
0  
1  
2  
3  
Heart rate  
-1-15% above preoperative value  
-16-29% above preoperative value  
-30-45% above preoperative value  
->45% above preoperative value  
  
  
0  
1  
2  
3  
  
0  
1  
2  
3  
  
0  
1  
2  
3  
  
0  
1  
2  
3  
  
0  
1  
2  
3  
  
0  
1  
2  
3  
  
0  
1  
2  
3  
  
0  
1  
2  
3  
Respiratory rate  
-1-15% above preoperative value  
-16-29% above preoperative value  
-30-45% above preoperative value  
->45% above preoperative value  
  
  
0  
1  
2  
3  
  
0  
1  
2  
3  
  
0  
1  
2  
3  
  
0  
1  
2  
3  
  
0  
1  
2  
3  
  
0  
1  
2  
3  
  
0  
1  
2  
3  
  
0  
1  
2  
3  
Total (0-13)    
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Appendix 2 
Modified Tarlov’s scale (Buvanendran et al., 2002; Adami et al., 2016) to evaluate the neurological 
function of the hind limbs and the degree of motor blockade in 20 dogs undergoing total hip 
replacement.  
The same observer who was blind to the treatment evaluated the dogs as soon as they were awake 
enough to respond to stimulation (vocal call and incitement to sit or stand up) and then 60, 120, 
180, 240, 300 minutes and 24 hours after surgery.   
 
Grade 0 Flaccid paraplegia, no movements of the hind limbs, possible loss of bowel/ urinary 
bladder control 
Grade 1 Spastic paraplegia with moderate or vigorous purposeless movements of the hind 
limbs. No sitting, unable to walk 
Grade 2 Good movements of the hind limbs but unable to stand   
 
Grade 3 Able to stand but unable to walk normally; hips and limbs obviously unstable, 
moderate to severe ataxia 
Grade 4 Able to stand and walk normally, some muscle weakness of the hind limbs may be 
seen   
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Figure legends 
 
Figure 1 Intraoperative physiological variables recorded from 20 dogs anaesthetized for total hip 
replacement and assigned to one of two treatment groups: group C (Control, epidural ropivacaine;  
n = 10) and group M (Magnesium, epidural combination of magnesium and ropivacaine;  n = 10). 
Data are presented as mean ± standard deviation. 0: values recorded as baseline in the anaesthetized 
dogs prior to surgical stimulation; 1: values recorded immediately after skin incision; 2: values 
recorded after femoral head osteotomy.  
Footnotes: 
Mean arterial pressure 
†Significantly different from baseline for Group M (p value < 0.05, q value = 8.80) 
‡Significantly different from baseline for Group C (p value < 0.05) 
Respiratory rate 
†Significantly different from baseline for Group M (p < 0.05, q > 8.00) 
‡Significantly different from baseline for Group C (p < 0.05, q = 8.40) 
 
 
Figure 2 Postoperative pain scores recorded from 20 dogs anaesthetized for total hip replacement 
and assigned to one of two treatment groups: group C (Control, epidural ropivacaine; n = 10) and 
group M (Magnesium, epidural combination of magnesium and ropivacaine; n = 10). Data are 
presented as medians and interquartile ranges (25%-75%). 1: values recorded after recovery, as 
soon as the patients were able to sit and respond to vocal call; 2, 3, 4, 5 and 6 are 60, 120, 180, 240, 
300 minutes and 24 hours after recovery.  
Footnotes 
Sammarco score  
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†Significantly different from baseline for Group M (p value < 0.05) 
‡Significantly different from baseline for Group C (p value < 0.05)  
Visual Analogue Scale score 
†Significantly different from baseline for Group M (p value < 0.05, q value = 12.16) 
‡Significantly different from baseline  for Group C (p value < 0.05, q value = 11.65) 
Tarlov’s score 
†Significantly different from baseline for Group M (p value < 0.05) 
‡Significantly different from baseline  for Group C (p value < 0.05) 
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